2019
DOI: 10.1002/eahr.500034
|View full text |Cite
|
Sign up to set email alerts
|

Safeguarding Participants in Psychiatric Genetic Research: Perspectives of Key Stakeholder Groups

Abstract: Public trust in research depends on implementation of research protections. Genetic and psychiatric research may elicit “exceptionalism,” the belief that these types of research deserve special protections. Genetic information has been viewed as different from other health information. Psychiatric research has been scrutinized based on concerns about the impact of psychiatric illness on individuals’ abilities to make decisions. This study compared four stakeholder groups’ attitudes toward research safeguards. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 26 publications
(38 reference statements)
0
1
0
Order By: Relevance
“…For instance, in some jurisdictions, a person who holds a durable power of attorney for health care (DPAHC) may be able to make a wide range of healthcare decisions for an incapacitated patient but be unable to authorize psychiatric care or certain types of psychiatric treatment in the absence of a special DPAHC for mental health care (Fleischner, 1998 ; Henderson et al, 2008 ). Thus, applying genetic and genomic tools, such as pedigree studies, genetic testing and screening, whole genome sequencing, whole exome sequencing, and genome wide association studies, to psychiatric disorders and stigmatized behaviors or symptoms often associated with such disorders raises special concerns (Adriaens & De Block, 2013 ; Appelbaum, 2004 ; Harris & Schaffner, 1992 ; Rostami et al, 2019 ; Rudnick, 2002 ). 1 Some of this work has led to concerns about eugenics and charges of racism (Sfera, 2013 ; Thomson, 2010 ; Berryesa and Cho, 2013 ; Hudson, 2009 ; Rembis, 2009 ; Pilgrim, 2008 ; Levitt, 2012 ).…”
Section: Introductionmentioning
confidence: 99%
“…For instance, in some jurisdictions, a person who holds a durable power of attorney for health care (DPAHC) may be able to make a wide range of healthcare decisions for an incapacitated patient but be unable to authorize psychiatric care or certain types of psychiatric treatment in the absence of a special DPAHC for mental health care (Fleischner, 1998 ; Henderson et al, 2008 ). Thus, applying genetic and genomic tools, such as pedigree studies, genetic testing and screening, whole genome sequencing, whole exome sequencing, and genome wide association studies, to psychiatric disorders and stigmatized behaviors or symptoms often associated with such disorders raises special concerns (Adriaens & De Block, 2013 ; Appelbaum, 2004 ; Harris & Schaffner, 1992 ; Rostami et al, 2019 ; Rudnick, 2002 ). 1 Some of this work has led to concerns about eugenics and charges of racism (Sfera, 2013 ; Thomson, 2010 ; Berryesa and Cho, 2013 ; Hudson, 2009 ; Rembis, 2009 ; Pilgrim, 2008 ; Levitt, 2012 ).…”
Section: Introductionmentioning
confidence: 99%